| CRC | Colorectal Cancer |
| Hb | Hemoglobin |
| FIT | Fecal Immunochemical Test |
| T | Tumor |
| N | Lymph Node |
| M | Metastasis |
| AIRs | Annual Incidence Rates |
| gFOBT | Guaiac-Based Fecal Occult Blood Test |
| H-sG-bFOBT | High-sensitive Guaiac-based Fecal Occult Blood Test |
| DNA | Deoxyribonucleic Acid |
| MT-sDNA | Multitarget-Stool DNA |
| sDNA | Stool-DNA |
| sRNA | Stool- Ribonucleic Acid |
| AA | Advanced Adenomas |
| SSLs | Sessile Serrated Lesions |
| mRNA | Messenger Ribonucleic Acid |
| cfDNA | Circulating Free DNA or Cell Free DNA |
| ID | Identification |
| CI | Confidence Interval |
| P | P-value |
| OR | Odds Ratio |
| SM | Screening Methods |
| V/N-v | Visual/Non-visual |
| SA | Start Age |
| SI | Screening Interval |
| S/S | Sensitivity/Specificity |
| AAD | Advancer Adenoma Detection |
| Ney | Not Established Yet |
| Sue | Still Under Evaluation |
| Bd-Shield | Blood-based–Shield test |
| NF | Not First-Line |
| AI | Artificial Intelligence |
| RT-qPCR | Reverse Transcription–Quantitative Polymerase Chain Reaction |
| CMS | Consensus Molecular Subtyping |
| TGF | Transforming Growth Factor |
| NADH | Nicotinamide Adenine Dinucleotide |